Hydrogenics Announces Board of Directors Appointment

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hydrogenics Announces Board of Directors Appointment

MISSISSAUGA, Ontario, Oct. 2, 2014 (GLOBE NEWSWIRE) -- Hydrogenics Corporation (Nasdaq: HYGS ) (TSX: HYG ), a leading developer and manufacturer of hydrogen generation and hydrogen-based power modules, announced that Mr. David C. Ferguson has been appointed to the Hydrogenics Board of Directors and its Audit Committee effective immediately.

Between 1999 and 2012, Mr. Ferguson was Executive Managing Director and Chief Financial Officer of BMO Capital Markets and was a member of the Board of Directors of BMO Nesbitt Burns. Prior to 1999 Mr. Ferguson had a 25 year career at KPMG including 16 years as an audit partner.

Mr. Ferguson is a member of the Board of Directors of GMP Securities and a former President and Board Chair of the Canadian Opera Company. Mr. Ferguson is Fellow of the Institute of Chartered Accountants of Ontario and a member of the Institute of Corporate Directors.

"We are very pleased to welcome David Ferguson to the Board at Hydrogenics," said Doug Alexander, Chairman of the Board of Hydrogenics. "David's in-depth financial acumen and his knowledge of the capital markets will prove invaluable to help guide Hydrogenics as we continue to grow our business and execute on our business strategy. David's extensive business and leadership experience will also be a tremendous asset to the Hydrogenics Board in the future."

About Hydrogenics

Hydrogenics Corporation ( www.hydrogenics.com ) is a globally recognized developer and provider of hydrogen generation and fuel cell products and services, serving the growing industrial and clean energy markets of today and tomorrow. Based in Mississauga, Ontario, Canada, Hydrogenics has operations in North America and Europe.

Forward-looking Statements

This release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995, and under applicable Canadian securities law. These statements are based on management's current expectations and actual results may differ from these forward-looking statements due to numerous factors, including: our inability to increase our revenues or raise additional funding to continue operations, execute our business plan, or to grow our business; inability to address a slow return to economic growth, and its impact on our business, results of operations and consolidated financial condition; our limited operating history; inability to implement our business strategy; fluctuations in our quarterly results; failure to maintain our customer base that generates the majority of our revenues; currency fluctuations; failure to maintain sufficient insurance coverage; changes in value of our goodwill; failure of a significant market to develop for our products; failure of hydrogen being readily available on a cost-effective basis; changes in government policies and regulations; failure of uniform codes and standards for hydrogen fuelled vehicles and related infrastructure to develop; liability for environmental damages resulting from our research, development or manufacturing operations; failure to compete with other developers and manufacturers of products in our industry; failure to compete with developers and manufacturers of traditional and alternative technologies; failure to develop partnerships with original equipment manufacturers, governments, systems integrators and other third parties; inability to obtain sufficient materials and components for our products from suppliers; failure to manage expansion of our operations; failure to manage foreign sales and operations; failure to recruit, train and retain key management personnel; inability to integrate acquisitions; failure to develop adequate manufacturing processes and capabilities; failure to complete the development of commercially viable products; failure to produce cost-competitive products; failure or delay in field testing of our products; failure to produce products free of defects or errors; inability to adapt to technological advances or new codes and standards; failure to protect our intellectual property; our involvement in intellectual property litigation; exposure to product liability claims; failure to meet rules regarding passive foreign investment companies; actions of our significant and principal shareholders; dilution as a result of significant issuances of our common shares and preferred shares; inability of US investors to enforce US civil liability judgments against us; volatility of our common share price; and dilution as a result of the exercise of options; and failure to meet continued listing requirements of Nasdaq. Readers should not place undue reliance on Hydrogenics' forward-looking statements. Investors are encouraged to review the section captioned "Risk Factors" in Hydrogenics' regulatory filings with the Canadian securities regulatory authorities and the US Securities and Exchange Commission for a more complete discussion of factors that could affect Hydrogenics' future performance. Furthermore, the forward-looking statements contained herein are made as of the date of this release, and Hydrogenics undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, unless otherwise required by law. The forward-looking statements contained in this release are expressly qualified by this.

Bob Motz Chief Financial Officer (905) 361-3660 Chris Witty Hydrogenics Investor Relations (646) 438-9385

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 100

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
Celebrating Science with Southeastern Tile's Sponsorship

Updated Category News Views 65

Crafting Pathways and Fostering Curiosity In this world of rapid change and relentless innovation, supporting education—especially in science and technology—is like buying a piece of the future. And, boy, is Southeastern Tile Connection onto something with that. They've stepped up as an Exploration Sponsor for the Asheville Museum of Science's (AMOS) annual gala,...

Continue Reading
PVA Unveils Hotel Accessibility Guide for Disabled Travelers

Updated Category News Views 169

Is Your Hotel Truly Accessible? Time to Find Out. Another day, another step toward making the world a bit more navigable for folks with mobility challenges—and it's about time the hospitality sector caught up. Today, Paralyzed Veterans of America (PVA) rolled out the first volume of their 'Best Practices in Hotel Accessibility Guide.' Think of it as a roadmap for hotels...

Continue Reading
Guizhou's Mountain Conference Pushes Tourism Evolution

Updated Category News Views 0

Climbing High: Guizhou's Tourism Summit The 2026 International Conference of Mountain Tourism and Outdoor Sports in Guizhou has kicked off with a heartfelt focus on merging natural allure with modern tourism. This isn't just another gathering; it's a powerhouse of international dialogue harbored right in China's dramatic landscape. Building on Unique Natural Assets...

Continue Reading
Lauri Thompson Joins UWSN Board: A New Era Begins

Updated Category News Views 56

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 150

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
Summit Midstream's Q3 Financial Results Signal Growth

Updated Category News Views 47

Summit Midstream Delivers Strong Q3 Results Good grief, you'd think the grease is sliding off the griddle with these numbers. Summit Midstream Corporation (NYSE:SMC) is putting up figures that ought to make even the most poker-faced of traders crack a smile. We've got a net income sitting pretty at $15.9 million, and an Adjusted EBITDA that's climbed up to $70.7 million....

Continue Reading
Dutch Consumers Open to Recycling, Trust Lags Behind

Updated Category News Views 0

Dutch Consumers: Committed But Skeptical You think positive outlooks on clothing recycling mean business is booming, but scratch beneath the surface, and you'll find over 80% of Dutch consumers keen on recycling—but half of them think their efforts might be going to waste. Reju, a trailblazer in textile regeneration, gathered insights from more than a thousand Dutch...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 69

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading
Edgewise Therapeutics' Investor Play: What's the Buzz?

Updated Category News Views 95

Edgewise Therapeutics Maps Out Investor Terrain Alright, Edgewise Therapeutics, folks. They're shaking things up, and I mean that literally and figuratively. This clinical-stage cardiac biotech isn’t just sitting on its hands; they're out there hustling at the Guggenheim 3rd Annual Healthcare Innovation Conference. Buckle up, because the heart of their...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyundai America Technical Center Fuels Safety Initiatives

Updated Category News Views 173

Here’s the deal: Hyundai America Technical Center, Inc. (HATCI) just plopped down a cool $25,000 into C.S. Mott Children's Hospital’s safety initiatives. That cash is going straight into free resources like car seats and helmets—vital stuff for the community, especially when it comes to keeping kids safe on the streets. What’s the angle here? HATCI isn’t just...

Continue Reading
The Future of Precious Metals Amid USD Strength: Insights

Updated Category News Views 255

Understanding the Current Landscape of Precious Metals In recent times, the precious metals market, particularly gold and silver, has been witnessing significant fluctuations. Analysts have observed that while gold futures have experienced a notable increase, this may not align with broader market signals. Gold Futures and Market Dynamics The gold futures market recently...

Continue Reading
Man Group PLC's Strategic Position in Financial Markets

Updated Category News Views 205

Man Group PLC's Strategic Disclosure Overview In the dynamic world of finance, transparency and accountability play crucial roles in maintaining investor confidence. Man Group PLC, a prominent player on the London Stock Exchange, is dedicated to adhering to these principles. This article delves into the recent public opening position disclosures made by Man Group PLC,...

Continue Reading
Bio-Path Initiates Obesity Program with BP1001-A Candidate

Updated Category News Views 86

Bio-Path's New Venture into Obesity Treatment Bio-Path Holdings, Inc. has taken a significant leap forward by initiating a new therapeutic program focused on obesity and related metabolic diseases. This groundbreaking program revolves around the development of BP1001-A, leveraging their proprietary DNAbilize technology. This marks an exciting shift in direction, as it is...

Continue Reading
Active Pharmaceutical Ingredients Market Growth and Trends to Watch

Updated Category News Views 175

Transforming the Pharmaceutical Landscape through APIs The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is revolutionizing how drugs are developed and produced globally. Active Pharmaceutical Ingredients (APIs) have transitioned from being mere components in drug production to essential assets that...

Continue Reading